Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Lithuania

Marie Skłodowska-Curie Action · Running

NANOPEC Development of a Nanohybrid System Based Wearable Microfluidic Photoelectrochemical Sensor for the On-demand Ctni Detection (nanopec)

Coordinator
Kauno Technologijos Universitetas, Lithuania
Runs
1 February 2027 to 31 January 2029
Status
Running
EU funding
€197k
Total cost
—
Partners
3 organisations in 3 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101278160

What the project is doing

In the project's own words, from its summary on CORDIS.

Development of a Nanohybrid System Based Wearable Microfluidic Photoelectrochemical Sensor for the On-Demand cTnI DetectionThe Acute Myocardial Infarction (AMI) demands instant diagnosis, since the currently existing technologies remain invasive, expensive, time-consuming, and confined to clinical setups. The project NANOPEC proposed for the MSCA PF application hosts an innovative solution with the development of a wearable, biorecognition-free, microfluidic photoelectrochemical (PEC) saliva sensor for the ultrasensitive detection of cardiac troponin (cTnI).

Fundamentally, it lies in a unique zinc oxide tetrapod-graphene quantum dot (ZnOTPD/GQD)-based nanohybrid system, while GQD will be derived sustainably from plastic waste. Embedding this into a flexible, wearable patch will enable the on-demand real-time monitoring of cTnI levels. This project relies on the following key deliverables: Development of GQD with quantum yield > 50% with photoinduced charge transfer efficiency over 85% within the nanohybrid, Fabrication of a durable, microfluidic PEC patch withstanding at least 50 cycles while keeping a stable performance, ultrasensitive detection with an expected limit of detection < 5 pg/ml, and validation of the sensor performance with artificial saliva matrices with reproducibility (expected RSD under 8%) and robustness against common interfering analytes.

By interlinking nanotechnology, material science, and wearable diagnostics, NANOPEC will open up a way for a low-cost, scalable, sustainable, non-invasive, on-set diagnostic tool, which will improve clinical outcomes and reduce the global mortality rate.

Topics

Who is involved

OrganisationCityCountryRole
Kauno Technologijos UniversitetasKaunasLithuaniaCoordinator
Universite Paris CiteParisFranceAssociatedpartner
Uniwersytet Im. Adama Mickiewicza WpoznaniuPoznanPolandAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI